Pfizer
Jose Ma. Alvir has extensive experience in public health and statistics, currently serving as Senior Director at Pfizer since August 2004. Prior roles include membership in the Medicare Evidence Development and Coverage Advisory Committee from 2007 to 2009 and Athletics Chairman on the Board of Governors at Strathmore Vanderbilt Country Club from 1998 to 2006. Additional experience encompasses positions as Director at NYU (2001-2004), Senior Statistician at Hillside Hospital (1985-2001), and Deputy Project Director at the Research Foundation for Mental Hygiene (1982-1985). Jose Ma. Alvir is an alumnus of Columbia University Mailman School of Public Health, where a DrPH degree was earned (1980-1985), and also attended the University of the Philippines (1970-1974) and San Beda College (1966-1969) for earlier education.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.